Patrick Gliha
About Patrick Gliha
Patrick Gliha is the Executive Director of Global Alliances at Bristol Myers Squibb, overseeing external alliances from early discovery through commercialization, with a focus on Asia.
Current Role at Bristol Myers Squibb
Patrick Gliha serves as the Executive Director, Global Alliances at Bristol Myers Squibb in the New York City Metropolitan Area. In this role, he oversees a portfolio of external alliances that span from early discovery through commercialization. He maintains particular oversight for the BMS external alliance portfolio in Asia, focusing on Japan and China. Gliha leads a team of highly talented Alliance Leaders with a significant global book of work and is a member of the BMS Global Alliances Leadership Team.
Previous Experience at Bristol Myers Squibb
Before his current role, Patrick Gliha was the Senior Director, Regional Lead for State Government Affairs at Bristol Myers Squibb from 2019 to 2021. Based in Cleveland, Ohio, he was responsible for shaping and managing the company's state government relations strategy. His tenure in this role spanned 2 years.
Work History at Celgene
Patrick Gliha worked at Celgene in various capacities. From 2018 to 2019, he served as the Senior Director, Head of State Government Relations in the Washington D.C. Metro Area. He was responsible for managing state government relations strategies and policies. Prior to that, Gliha held the position of Director, Federal Government Relations at Celgene from 2014 to 2018, overseeing federal government interactions and policy advocacy.
Career at Amgen
Patrick Gliha was employed by Amgen as the Senior Manager of U.S. Government Affairs from 2009 to 2014 in Washington D.C. Metro Area. During his 5-year tenure, he managed Amgen's relationships and advocacy efforts with the U.S. government, focusing on influencing policy and regulatory matters.
Education Background
Patrick Gliha holds a Master of Business Administration (MBA) degree from Ohio University. He also studied Political Science and earned a B.A. from The University of Akron. His educational background has provided a strong foundation for his roles in government relations and external alliances in the biopharmaceutical sector.